Semaglutide · 20 mg
Published- batch · LOT
- B-2026-SEMA-20-002
- Laboratory
- MZ Biolabs
- purity
- 99.92%
- Test date
- 22.09.2026
Analytics cookies help us understand what works in the catalog. Accept all, reject non-essential ones, or choose categories below. Privacy policy
A weight-control peptide: a copy of the GLP-1 hormone, injected once a week. In the pivotal study, people lost 14.9% of their weight on average over 68 weeks.
Titration schedule · reference
The information below is provided from public sources for reference only. It is not advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Period / condition | Dose | Escalation |
|---|---|---|
| Weeks 1–4 | 0.25 mg weekly | Starting dose |
| Weeks 5–8 | 0.5 mg weekly | Increase if tolerated |
| Weeks 9–16 | 1.0–1.7 mg weekly | Gradual increase |
| From week 17 | 2.4 mg weekly | Maximum in this schedule |
Research overview · reference
Below is a short summary of what the authors of published studies reported. It is not medical advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Nausea, diarrhea | 1961 adults with obesity or overweight plus a weight-related condition, without diabetes, 2.4 mg or placebo, 68 weeks | Most common events, typically transient and mild to moderate; stopping because of gastrointestinal events 4.5% versus 0.8% | [1] |
| Gastrointestinal events overall | 1210 adults with type 2 diabetes, 68 weeks | 63.5% (2.4 mg), 57.5% (1.0 mg) versus 34.3% on placebo | [2] |
| Gastrointestinal events overall | 304 adults with obesity or overweight plus a weight-related condition, without diabetes, 104 weeks | 82.2% versus 53.9% on placebo, mostly mild to moderate | [3] |
FAQ
Find answers to questions about Semaglutide and related materials.
Acylation with C18 diacid is a chemical modification that allows the Semaglutide molecule to bind to albumin in the blood. This significantly extends the circulation period of the drug in the body and is a key feature of its pharmacodynamics as a selective GLP-1 receptor agonist.
Source / documentationSemaglutide is available in three package sizes: 5 mg, 20 mg, and 50 mg. The difference is only in the quantity of the product—your choice depends on the scope of your research projects. The chemical composition, purity, and quality are identical for all packages.
Source / documentationThe purity information for Semaglutide is provided in the Certificate of Analysis (CoA), which is supplied for each batch. The document includes independent laboratory analysis results and guarantees product quality. Request the CoA from us based on your order batch number.
Source / documentation"Research use only" means that Semaglutide is intended exclusively for laboratory research and in vitro/in vivo experiments for scientific purposes. This product has not been evaluated by regulatory authorities for human use, so it is prohibited to use it for diagnosis, treatment, or disease prevention.
Source / documentationThe shelf life after reconstitution depends on the solvent chosen and storage conditions. Reconstituted solutions should generally be used as soon as possible and stored at 2–8 °C. Specific recommendations are provided in the product documentation and Certificate of Analysis.
Source / documentationSemaglutide is supplied as a lyophilized powder. Store the product in a cool, dry place at 2–8 °C (in a refrigerator) in a sealed, light-protected container until the package is opened.
Source / documentationEach batch of Semaglutide is accompanied by a Certificate of Analysis from an independent laboratory. To obtain the CoA, provide your order batch number to our support team. The document contains detailed test results for product quality and purity.
Source / documentationIt is a peptide for weight and blood-sugar control — a copy of the GLP-1 hormone the body releases after meals. It strengthens fullness and helps control sugar, so it is used for weight loss and in type 2 diabetes. It is injected once a week.
Source / documentationThe powder is dissolved with bacteriostatic water and injected under the skin once a week — into the abdomen, thigh or upper arm. The dose goes up one step every 4 weeks: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg; 2.4 mg is the maintenance dose of the weight-control schedule. The full schedule is in the dosing guide on this page.
Source / documentationOzempic is Novo Nordisk's brand name for a finished medicine containing semaglutide; Wegovy is the same medicine in the weight schedule, and Rybelsus is the tablet form. We sell the semaglutide molecule itself as a dry powder, not those brands.
Source / documentationTirzepatide acts on two receptors (GIP and GLP-1), semaglutide on one (GLP-1), and in studies tirzepatide on average produced greater weight loss. Semaglutide has been on the market longer, is studied more, and is often gentler at the start. The choice depends on what matters more: the maximum result or a calmer beginning.
Source / documentationThe most common are nausea, sometimes vomiting, diarrhea or constipation; they are strongest at the start and when the dose goes up, which is why the dose is raised slowly. The full safety profile, including rare serious risks, is covered in the semaglutide monograph in our wiki.
Source / documentationMost often the reason is simple: the dose has not reached the working level yet (the first steps, 0.25–0.5 mg, barely have an effect — they are for adjustment), or the course is still short: in studies, results were measured over a year or more. If the weight stalls for a few months on the full dose, people look at tirzepatide, which acts on two receptors.
Source / documentationThere is no direct ban in the studies, but alcohol adds calories and can worsen nausea and blood-sugar swings, so people usually limit it during a course. If you drink, avoid an empty stomach and the injection day.
Source / documentationYou can buy semaglutide right on this page of our store: choose a pack size; current prices and stock are shown in the product card. We deliver across Ukraine with Nova Poshta — to a branch, a parcel locker, or by courier. Payment is by card, by crypto (with a 5% discount), or on delivery. Every vial ships with the certificate of analysis (COA) for its exact batch.
Source / documentationThe half-life of semaglutide is approximately 1 week (about 7 days). The figure is stated in the FDA label (section 12.3) and confirmed by human pharmacokinetic studies. This long half-life comes from C18 diacid acylation and albumin binding. See the Dosing section for detail.
Source / documentationCertificates shown: 3
Selected size: 5 mg
5 mg analysis published
Research, properties and limitations
AI can make mistakes
Share your experience
No reviews yet. Tell others what you think of this product.
Semaglutide is a peptide for weight and blood-sugar control. It is a copy of the GLP-1 hormone, which the body releases after meals: GLP-1 tells the pancreas to release insulin and the brain that we are full. Semaglutide strengthens both signals for far longer than our own hormone: it stays in the body for about a week, so it is injected only once a week.
What it does: in the main STEP study, people receiving semaglutide lost on average 14.9% of their weight over 68 weeks — versus 2.4% on placebo. In the SUSTAIN programme it was studied for blood-sugar control in type 2 diabetes.
How it is used: the vial holds a dry powder (lyophilisate). It is dissolved with bacteriostatic water and injected under the skin once a week. The dose is raised slowly, one step every 4 weeks: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg, so the body can adjust and nausea stays milder. The exact schedule is in the dosing guide on this page.
Brands: the same molecule is sold worldwide as Novo Nordisk's finished medicines — Ozempic (for diabetes), Wegovy (for weight) and Rybelsus (tablets). We sell the molecule itself, not a brand. How a brand differs from the substance is covered in our articles on Ozempic, Wegovy and Rybelsus; the daily neighbour is covered in our Saxenda article.
Batch and COA: every batch is tested by an independent laboratory. Find the LOT number on your vial and open the certificate of analysis (COA) for that exact batch in our COA archive — it lists the substance name, the test methods (HPLC among them) and the results. Typical purity is 98–99%.
Comparison: tirzepatide acts on two receptors at once (GIP and GLP-1) and on average produces stronger weight loss in studies; liraglutide is the older drug in the class but is injected daily. The full line is on the GLP-1 peptides category page.
Documentation and storage: batch details, the specification and storage conditions are kept on the documentation page. In short: dry powder in a dry, dark place at a low temperature; once dissolved, in the refrigerator. The scientific details — molecular structure, the C18 modification and a review of the studies — are in our wiki article on semaglutide.
Buy 2, get the 3rd free
The set contains two vials of 50 mg.
100 mg: Best value · Save ≈ $73.39